Physician

Ashit Jain, M.D.

According to 2025 Medicare claims, Ashit Jain, M.D. (NPI: 1154344919) practices cardiology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Alameda, CA. This provider's primary affiliated billing organization is CALIFORNIA CARDIOVASCULAR CONSULTANTS (NPI: 1932202959; TIN: 94-3236308) and primary practice location at 94538-1626.

Jain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,323 traditional Medicare patients, billed 33,423 HCPCS/CPT codes, and received $2,846,739 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 12,891 prescription claims across 1,181 beneficiaries totaling $1,764,783 in drug costs, led by Eliquis (Apixaban). DME data shows 1,123 claims. Open Payments data shows 202 records totaling $353,870. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,784,472 to $2,846,739. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $615,864 to $1,764,783. In contrast, DME billing represents a smaller volume and rose steadily, from $5,437 to $91,109.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2015 Medicare payment: $1,784,472 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,823,202 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,974,026 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,201,134 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,357,138 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,536,787 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,127,258 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,482,202 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,386,911 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,846,739 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,44931,577$1,784,472
20161,55435,360$1,823,202
20171,66638,950$1,974,026
20182,10737,957$2,201,134
20192,20038,384$3,357,138
20201,54135,149$2,536,787
20211,78939,785$3,127,258
20222,05335,799$2,482,202
20231,79533,573$2,386,911
20243,32333,423$2,846,739

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$906K$1.8M2015 Drug cost: $615,864 (USD; Tot_Drug_Cst)2016 Drug cost: $629,621 (USD; Tot_Drug_Cst)2017 Drug cost: $718,898 (USD; Tot_Drug_Cst)2018 Drug cost: $884,325 (USD; Tot_Drug_Cst)2019 Drug cost: $1,193,933 (USD; Tot_Drug_Cst)2020 Drug cost: $1,294,534 (USD; Tot_Drug_Cst)2021 Drug cost: $1,459,729 (USD; Tot_Drug_Cst)2022 Drug cost: $1,509,531 (USD; Tot_Drug_Cst)2023 Drug cost: $1,811,261 (USD; Tot_Drug_Cst)2024 Drug cost: $1,764,783 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201591410,098$615,864
20168679,500$629,621
20178349,856$718,898
201890310,380$884,325
201989911,138$1,193,933
202086611,079$1,294,534
202191411,676$1,459,729
202299810,505$1,509,531
20231,15411,901$1,811,261
20241,18112,891$1,764,783

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$20K$40K2015 Medicare payment: $6,139 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $3,463 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $2,663 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $8,171 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $10,430 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $11,914 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $16,778 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $13,934 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $27,758 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $39,679 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201565228$6,139
201630121$3,463
201729101$2,663
201898315$8,171
2019113424$10,430
2020110490$11,914
2021119642$16,778
2022107574$13,934
2023189682$27,758
20242821,123$39,679

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function833870$155
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1,0814,615$101
99490Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month2,1943,718$45
80053Blood test, comprehensive group of blood chemicals7381,416$10
36415Insertion of needle into vein for collection of blood sample7641,577$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban57439,217$757,218
XareltoRivaroxaban29820,393$373,904
JardianceEmpagliflozin342,488$45,989
Trelegy ElliptaFluticasone/Umeclidin/Vilanter572,160$42,589
JanuviaSitagliptin Phosphate171,290$23,367

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0260Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattressY29179$7,842
K0003Lightweight wheelchairY26157$4,129
A4239Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceNN/R12$2,307
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R29$2,074
E0601Continuous positive airway pressure (cpap) deviceY1266$2,067

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$1,268Janssen Research & Development, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.189$352,602Novo Nordisk Inc
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ashit Jain, M.D.?

Tedicare shows public-source Medicare data for Ashit Jain, M.D. (NPI 1154344919), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ashit Jain, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ashit Jain, M.D.?

Ashit Jain, M.D. is linked to CALIFORNIA CARDIOVASCULAR CONSULTANTS (billing NPI 1932202959) in the available physician profile data.

Does Ashit Jain, M.D. have Open Payments data?

Ashit Jain, M.D. has 202 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.